CellaVision AB (publ)
CLVSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6,836,616 | $4,016,190 | $5,574,928 | $7,383,594 |
| - Cash | $149,430 | $121,645 | $108,053 | $130,286 |
| + Debt | $26,849 | $64,703 | $102,495 | $136,654 |
| Enterprise Value | $6,714,035 | $3,959,248 | $5,569,370 | $7,389,962 |
| Revenue | $723,217 | $677,292 | $639,340 | $565,552 |
| % Growth | 6.8% | 5.9% | 13% | – |
| Gross Profit | $487,074 | $463,041 | $438,317 | $392,302 |
| % Margin | 67.3% | 68.4% | 68.6% | 69.4% |
| EBITDA | $219,751 | $207,245 | $190,866 | $193,600 |
| % Margin | 30.4% | 30.6% | 29.9% | 34.2% |
| Net Income | $140,722 | $130,309 | $118,335 | $125,339 |
| % Margin | 19.5% | 19.2% | 18.5% | 22.2% |
| EPS Diluted | 5.9 | 5.46 | 4.96 | 5.25 |
| % Growth | 8.1% | 10.1% | -5.5% | – |
| Operating Cash Flow | $198,438 | $196,436 | $137,285 | $159,717 |
| Capital Expenditures | -$77,749 | -$86,476 | -$69,434 | -$84,306 |
| Free Cash Flow | $120,689 | $109,960 | $67,851 | $75,411 |